董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Ron Mayron | 男 | Chairman of the Board | 58 | 未披露 | 未持股 | 2021-08-08 |
| Eyal Shamir | 男 | Chief Executive Officer, Director | 60 | 42.00万美元 | 未持股 | 2021-08-08 |
| Yang Huang | 男 | Director | 42 | 未披露 | 未持股 | 2021-08-08 |
| Oded Tamir | 男 | Director | 65 | 未披露 | 未持股 | 2021-08-08 |
| Doron Birger | 男 | Director | 70 | 未披露 | 未持股 | 2021-08-08 |
| Sharon Levita | 女 | Director | 53 | 未披露 | 未持股 | 2021-08-08 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Eyal Shamir | 男 | Chief Executive Officer, Director | 60 | 42.00万美元 | 未持股 | 2021-08-08 |
| Ronen Tsimerman | 男 | Chief Financial Officer, Chief Operation Officer | 51 | 29.80万美元 | 未持股 | 2021-08-08 |
| Shay Levav | 男 | Vice President, Regulatory and Quality Assurance and Clinical Applications | 44 | 7.80万美元 | 未持股 | 2021-08-08 |
| Tlalit Bussi Tel Tzure | 女 | Vice President, Business Development and Global Marketing | 49 | 26.30万美元 | 未持股 | 2021-08-08 |
| Naum Muchnik | 男 | Vice President, Research, Development and Engineering | 44 | 23.60万美元 | 未持股 | 2021-08-08 |
董事简历
中英对照 | 中文 | 英文- Ron Mayron
-
Ron Mayron，他也曾任职Icecure Medical Ltd.的董事会，担任独立董事（2011年4月以来），也是Icecure Medical Ltd.的审计、薪酬、财务报表、公司治理和投资委员会的成员。他担任ADY Consulting Group的战略和业务顾问。任职ADY Consulting Group之前，他曾担任Netafim公司的联席首席执行官。此前，他曾担任Teva公司的多种高级职务20年以上，包括高级商业开发副总裁、首席信息官、中欧和东欧副总裁。他持有Bar Ilan University的经济学学士学位。
Ron Mayron has served as Chairman of Icecure Medical Ltd. board of directors since December 2017. Mr. Mayron has served as chairman of the board of directors of Resymmetry Ltd. since July 2016 InnoCan Pharma Corporation CSE: INNO, FWB: IP4 OTC: INNPF since November 2017 and Virility Medical LTD since October 2019 and as a member of the board of directors of BioLight Life Sciences Investments Ltd. (TASE: BOLT) since August 2015 G-Med Ltd. since September 2015 Kaizen Bio-Tec Ltd. since May 2017 Simplivia Ltd. since May 2019 and Kadimastem LTD (TASE: KDST) since December 2020. Mr. Mayron has also served as the founder and chief executive officer of RonMed Ltd. Prior to that, Mr. Mayron has served as chairman of the board of directors of Wize Pharma Inc. (OTC: WIZP) from April 2015 to October 2018 and Ocon Medical Ltd from January 2015 to November 2016 and as a member of the board of directors of EclipeIR (USA) Inc from June 2016 to September 2019. Mr. Mayron has also served in various positions at Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) from 1993 to 2014 including as vice president -Israel and Africa and chief executive officer of Teva Israel from 2009 to 2013. Mr. Mayron received his B.Sc. in industrial and management engineering from Ben-Gurion University of the Negev, Israel and MBA from Tel-Aviv University, Israel. Mr. Mayron also completed a special senior management and global leadership programs at the Massachusetts Institute of Technology (M.I.T), Boston and managerial skills for international business and executive international marketing programs at Insead University, France. - Ron Mayron，他也曾任职Icecure Medical Ltd.的董事会，担任独立董事（2011年4月以来），也是Icecure Medical Ltd.的审计、薪酬、财务报表、公司治理和投资委员会的成员。他担任ADY Consulting Group的战略和业务顾问。任职ADY Consulting Group之前，他曾担任Netafim公司的联席首席执行官。此前，他曾担任Teva公司的多种高级职务20年以上，包括高级商业开发副总裁、首席信息官、中欧和东欧副总裁。他持有Bar Ilan University的经济学学士学位。
- Ron Mayron has served as Chairman of Icecure Medical Ltd. board of directors since December 2017. Mr. Mayron has served as chairman of the board of directors of Resymmetry Ltd. since July 2016 InnoCan Pharma Corporation CSE: INNO, FWB: IP4 OTC: INNPF since November 2017 and Virility Medical LTD since October 2019 and as a member of the board of directors of BioLight Life Sciences Investments Ltd. (TASE: BOLT) since August 2015 G-Med Ltd. since September 2015 Kaizen Bio-Tec Ltd. since May 2017 Simplivia Ltd. since May 2019 and Kadimastem LTD (TASE: KDST) since December 2020. Mr. Mayron has also served as the founder and chief executive officer of RonMed Ltd. Prior to that, Mr. Mayron has served as chairman of the board of directors of Wize Pharma Inc. (OTC: WIZP) from April 2015 to October 2018 and Ocon Medical Ltd from January 2015 to November 2016 and as a member of the board of directors of EclipeIR (USA) Inc from June 2016 to September 2019. Mr. Mayron has also served in various positions at Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) from 1993 to 2014 including as vice president -Israel and Africa and chief executive officer of Teva Israel from 2009 to 2013. Mr. Mayron received his B.Sc. in industrial and management engineering from Ben-Gurion University of the Negev, Israel and MBA from Tel-Aviv University, Israel. Mr. Mayron also completed a special senior management and global leadership programs at the Massachusetts Institute of Technology (M.I.T), Boston and managerial skills for international business and executive international marketing programs at Insead University, France.
- Eyal Shamir
-
Eyal Shamir自2016年9月起担任我们的首席执行官，自2017年12月起担任董事会成员。Shamir先生拥有超过15年的医疗设备公司首席执行官的经验。他曾担任Erika Carmel Ltd.（2013年5月至2016年8月）、Tadbik Pack Ltd.（2011年1月至2012年12月）和Hanita Lens Ltd.（2006年至2010年）的首席执行官。Shamir先生在以色列希伯来大学获得经济学和商业管理学士学位，在以色列管理学院获得工商管理硕士学位。
Eyal Shamir has served as our Chief Executive Officer since September 2016 and on our board of directors since December 2017. Mr. Shamir has over 15 years of experience as chief executive officer of medical device companies. He has served as chief executive officer of Erika Carmel Ltd. from May 2013 to August 2016 Tadbik Pack Ltd. from January 2011 to December 2012 and Hanita Lenses Ltd. from 2006 to 2010. Mr. Shamir received his B.A. in economics and business management from the Hebrew University, Israel and his MBA from the College of Management Academic Studies, Israel. - Eyal Shamir自2016年9月起担任我们的首席执行官，自2017年12月起担任董事会成员。Shamir先生拥有超过15年的医疗设备公司首席执行官的经验。他曾担任Erika Carmel Ltd.（2013年5月至2016年8月）、Tadbik Pack Ltd.（2011年1月至2012年12月）和Hanita Lens Ltd.（2006年至2010年）的首席执行官。Shamir先生在以色列希伯来大学获得经济学和商业管理学士学位，在以色列管理学院获得工商管理硕士学位。
- Eyal Shamir has served as our Chief Executive Officer since September 2016 and on our board of directors since December 2017. Mr. Shamir has over 15 years of experience as chief executive officer of medical device companies. He has served as chief executive officer of Erika Carmel Ltd. from May 2013 to August 2016 Tadbik Pack Ltd. from January 2011 to December 2012 and Hanita Lenses Ltd. from 2006 to 2010. Mr. Shamir received his B.A. in economics and business management from the Hebrew University, Israel and his MBA from the College of Management Academic Studies, Israel.
- Yang Huang
-
Yang Huang自2020年4月以来一直在我们的董事会任职。Huang先生在医疗器械领域拥有20年的高级销售与市场营销管理经验。黄先生自2019年7月起还担任私募股权基金Virtus Inspire Ventures的运营董事，自2020年7月起担任Icecure Shanghai Medtech Co.，Ltd.的企业代表，此前，黄先生于2016年11月至2019年7月担任奥林巴斯（北京）销售服务有限公司业务单元总监，并于2015年1月至2016年11月担任B.Braun医疗（上海）国际贸易有限公司业务单元总监。黄先生毕业于中国长江商学院和中国浙江医科大学。
Yang Huang has served on our board of directors since April 2020. Mr. Huang has 20 years of senior sales and marketing management experience in the field of medical devices. Mr. Huang has also served as operation directors of Virtus Inspire Ventures, a private equity fund, since July 2019 and as a corporate representative of IceCure Shanghai MedTech Co., Ltd. since July 2020 Prior to that, Mr. Huang has served as business unit director of Olympus (Beijing) Sales & Service Co., Ltd. from November 2016 to July 2019 and as business unit director of B. Braun MEDICAL (SHANGHAI) International Trading Co., Ltd. from January 2015 to November 2016. Mr. Huang has graduated from Cheung Kong Graduate School of Business, China and Zhejiang Medical University, China. - Yang Huang自2020年4月以来一直在我们的董事会任职。Huang先生在医疗器械领域拥有20年的高级销售与市场营销管理经验。黄先生自2019年7月起还担任私募股权基金Virtus Inspire Ventures的运营董事，自2020年7月起担任Icecure Shanghai Medtech Co.，Ltd.的企业代表，此前，黄先生于2016年11月至2019年7月担任奥林巴斯（北京）销售服务有限公司业务单元总监，并于2015年1月至2016年11月担任B.Braun医疗（上海）国际贸易有限公司业务单元总监。黄先生毕业于中国长江商学院和中国浙江医科大学。
- Yang Huang has served on our board of directors since April 2020. Mr. Huang has 20 years of senior sales and marketing management experience in the field of medical devices. Mr. Huang has also served as operation directors of Virtus Inspire Ventures, a private equity fund, since July 2019 and as a corporate representative of IceCure Shanghai MedTech Co., Ltd. since July 2020 Prior to that, Mr. Huang has served as business unit director of Olympus (Beijing) Sales & Service Co., Ltd. from November 2016 to July 2019 and as business unit director of B. Braun MEDICAL (SHANGHAI) International Trading Co., Ltd. from January 2015 to November 2016. Mr. Huang has graduated from Cheung Kong Graduate School of Business, China and Zhejiang Medical University, China.
- Oded Tamir
-
Oded Tamir自2013年8月以来一直在我们的董事会任职。Tamir先生自2018年11月起还担任Fertigo Medical Ltd.的董事会主席，自2018年6月起担任Biodesign Israel（一个医疗创业和创新计划）的顾问委员会成员。在此之前，Tamir先生于2018年11月至2020年9月担任Imedis AI Ltd.的董事长，于2019年6月至2020年9月担任LensFree Ltd.的董事长，并于2013年6月至2016年12月担任RadLogics Inc.的总裁兼首席执行官。塔米尔先生获得了学士学位。以色列技术学院（Technion-Israel Institute of Technology）的经济学和企业管理专业，在以色列海法大学（University of Haifa）完成了高级会计研究，在以色列技术学院管理学院（Technion-Institute of Management）完成了高管发展管理项目，以色列和执行教育和培训项目在JohnF.Welch领导力发展中心，纽约。
Oded Tamir has served on our board of directors since August 2013. Mr. Tamir has also served as chairman of the board of directors of Fertigo Medical Ltd. since November 2018 and as a member of the advisory board of Biodesign Israel, a medical entrepreneurship and innovation program, from June 2018. Prior to that, Mr. Tamir has served as chairman of Imedis AI Ltd. from November 2018 to September 2020 and LensFree Ltd. from June 2019 to September 2020 and as president and chief executive officer of RADLogics Inc. from June 2013 to December 2016. Mr. Tamir received his B.Sc. in economics and business management from the Technion - Israel Institute of Technology, Israel completed advanced accounting studies at the University of Haifa, Israel executive development management program at the Technion - Institute of Management, Israel and executive education and training program at the John F. Welch Leadership Development Center, New York. - Oded Tamir自2013年8月以来一直在我们的董事会任职。Tamir先生自2018年11月起还担任Fertigo Medical Ltd.的董事会主席，自2018年6月起担任Biodesign Israel（一个医疗创业和创新计划）的顾问委员会成员。在此之前，Tamir先生于2018年11月至2020年9月担任Imedis AI Ltd.的董事长，于2019年6月至2020年9月担任LensFree Ltd.的董事长，并于2013年6月至2016年12月担任RadLogics Inc.的总裁兼首席执行官。塔米尔先生获得了学士学位。以色列技术学院（Technion-Israel Institute of Technology）的经济学和企业管理专业，在以色列海法大学（University of Haifa）完成了高级会计研究，在以色列技术学院管理学院（Technion-Institute of Management）完成了高管发展管理项目，以色列和执行教育和培训项目在JohnF.Welch领导力发展中心，纽约。
- Oded Tamir has served on our board of directors since August 2013. Mr. Tamir has also served as chairman of the board of directors of Fertigo Medical Ltd. since November 2018 and as a member of the advisory board of Biodesign Israel, a medical entrepreneurship and innovation program, from June 2018. Prior to that, Mr. Tamir has served as chairman of Imedis AI Ltd. from November 2018 to September 2020 and LensFree Ltd. from June 2019 to September 2020 and as president and chief executive officer of RADLogics Inc. from June 2013 to December 2016. Mr. Tamir received his B.Sc. in economics and business management from the Technion - Israel Institute of Technology, Israel completed advanced accounting studies at the University of Haifa, Israel executive development management program at the Technion - Institute of Management, Israel and executive education and training program at the John F. Welch Leadership Development Center, New York.
- Doron Birger
-
Doron Birger自2000年6月以来担任董事。从2002年8月到2007年7月他是Pluri Inc.的董事会主席。他现任Landmark Ventures Israel的董事总经理，担任Hadasit Bio-Holdings Ltd.（以色列上市生命科学公司）的董事，担任在以色列高科技领域的几家私人公司的董事和董事长。他从2002年8月到2009年4月担任Elron Electronic Industries, Ltd.（或Elron）的首席执行官。在此之前，他在Elron担任其他高管职位，包括自2001年以来担任总裁，从1994年到2002年8月担任首席财务官和从1994年到2001年担任公司秘书。直到2009年4月，他是RDC的董事，是Elron集团医疗设备，半导体和沟通领域的许多私营企业的董事或董事会主席。从1991年到1994年他是North Hills Electronics Ltd.（先进的电子公司）的首席财务官。他从1990年到1991年担任Middle-East Pipes Ltd.（金属行业的制造商）的首席财务官。他从1988年到1990年担任Maquette Ltd.（时尚产品的制造商和出口商）的首席财务官。从1981年到1988年他是Bateman Engineering Ltd.和I.D.C.Industrial Development Company Ltd.的首席财务官和董事。他持有耶路撒冷the Hebrew University的经济学学士学位和硕士学位。
Doron Birger,became a director of the Company in July 2021. Mr. Birger served as the chairman of the board of directors of Sight Diagnostic Ltd. from June 2014 until February 2024 and as interim CEO from July 2022 until March 2024, as chairman of the board of directors of Nurami Medical Ltd., or Nurami, from April 2016 to March 2022, and is currently a director of Nurami, Chairman or director of Ultrasight Medical Imaging Ltd. from June 2019, Intelicanna Ltd. (TASE: INTL) from April 2021 until April 2022, Matricelf Ltd. (TASE:MTLF ) from December 2020, Galooli from September 21 and as a director of IceCure Medical Ltd. (TASE: ICCM) since August 2012 until May 2024 , Vibrant Ltd. from December 2014 until March 2023, Hera Med Ltd. (ASX: HMD) from November 2019 until March 2024, Citrine Global (OTC: CTGL) from March 2020 until January 2024, Kadimastem Ltd. (TASE: KDST) from December 2020 until December 2023, VVT Medical since February 2024 and Netiv Ha'or, a subsidiary of the Israel Electric Corporation Ltd., from March 2020 until March 2023, and as chairman and director in a variety of non-profit organizations. Prior to that, Mr. Birger has served as Chairman or member of the board of directors of MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) from March 2015 to May 2018, Mekorot National Water Company Ltd. from November 2015 to November 2018, and chairman of the board of directors of Insulin Medical Ltd. (TASE: INSL) from March 2016 to August 2017, IOPtima Ltd. from June 2012 to June 2019, MST Medical Surgical Technologies Ltd. from August 2009 to June 2019, Highcon Ltd. From November 2014 to January 2018, Magisto Ltd. from September 2009 to July 2019, Real Imaging Ltd. from November 2018 to April 2019 and Medigus Ltd. (Nasdaq and TASE: MDGS) from May 2015 to September 2018. Mr. Birger holds a BA and MA in economics from the Hebrew University, Israel. - Doron Birger自2000年6月以来担任董事。从2002年8月到2007年7月他是Pluri Inc.的董事会主席。他现任Landmark Ventures Israel的董事总经理，担任Hadasit Bio-Holdings Ltd.（以色列上市生命科学公司）的董事，担任在以色列高科技领域的几家私人公司的董事和董事长。他从2002年8月到2009年4月担任Elron Electronic Industries, Ltd.（或Elron）的首席执行官。在此之前，他在Elron担任其他高管职位，包括自2001年以来担任总裁，从1994年到2002年8月担任首席财务官和从1994年到2001年担任公司秘书。直到2009年4月，他是RDC的董事，是Elron集团医疗设备，半导体和沟通领域的许多私营企业的董事或董事会主席。从1991年到1994年他是North Hills Electronics Ltd.（先进的电子公司）的首席财务官。他从1990年到1991年担任Middle-East Pipes Ltd.（金属行业的制造商）的首席财务官。他从1988年到1990年担任Maquette Ltd.（时尚产品的制造商和出口商）的首席财务官。从1981年到1988年他是Bateman Engineering Ltd.和I.D.C.Industrial Development Company Ltd.的首席财务官和董事。他持有耶路撒冷the Hebrew University的经济学学士学位和硕士学位。
- Doron Birger,became a director of the Company in July 2021. Mr. Birger served as the chairman of the board of directors of Sight Diagnostic Ltd. from June 2014 until February 2024 and as interim CEO from July 2022 until March 2024, as chairman of the board of directors of Nurami Medical Ltd., or Nurami, from April 2016 to March 2022, and is currently a director of Nurami, Chairman or director of Ultrasight Medical Imaging Ltd. from June 2019, Intelicanna Ltd. (TASE: INTL) from April 2021 until April 2022, Matricelf Ltd. (TASE:MTLF ) from December 2020, Galooli from September 21 and as a director of IceCure Medical Ltd. (TASE: ICCM) since August 2012 until May 2024 , Vibrant Ltd. from December 2014 until March 2023, Hera Med Ltd. (ASX: HMD) from November 2019 until March 2024, Citrine Global (OTC: CTGL) from March 2020 until January 2024, Kadimastem Ltd. (TASE: KDST) from December 2020 until December 2023, VVT Medical since February 2024 and Netiv Ha'or, a subsidiary of the Israel Electric Corporation Ltd., from March 2020 until March 2023, and as chairman and director in a variety of non-profit organizations. Prior to that, Mr. Birger has served as Chairman or member of the board of directors of MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) from March 2015 to May 2018, Mekorot National Water Company Ltd. from November 2015 to November 2018, and chairman of the board of directors of Insulin Medical Ltd. (TASE: INSL) from March 2016 to August 2017, IOPtima Ltd. from June 2012 to June 2019, MST Medical Surgical Technologies Ltd. from August 2009 to June 2019, Highcon Ltd. From November 2014 to January 2018, Magisto Ltd. from September 2009 to July 2019, Real Imaging Ltd. from November 2018 to April 2019 and Medigus Ltd. (Nasdaq and TASE: MDGS) from May 2015 to September 2018. Mr. Birger holds a BA and MA in economics from the Hebrew University, Israel.
- Sharon Levita
-
Sharon Levita，从2008年2月起担任公司的首席财务官。在加入Mazor之前，她于1999年至2008年在Lumenis Ltd.（一家医疗激光和光技术公司）担任多种职位，包括业务发展总监、财务执行副总裁和财务总监。她持有Bar-Ilan University的工商管理硕士学位（金融方向），还从Haifa University。获得了经济与会计的学士学位。她还是一名注册会计师。
Sharon Levita has served on our board of directors since September 2019. Ms. Levita also serves as business development and strategy leader at Medtronic. Prior to that, Ms. Levita has served as vice president operations and site leader of Mazor, as part of Medtronic, from December 2018 to January 2020 and as chief financial officer and vice president business operations of Mazor Robotics Ltd. from February 2008 to December 2018. Ms. Levita received her B.A in economics and accounting from the Haifa University, Israel and her M.A in business administration from the Bar-Ilan University, Israel. Ms. Levita is also a certificated public accountant in Israel. - Sharon Levita，从2008年2月起担任公司的首席财务官。在加入Mazor之前，她于1999年至2008年在Lumenis Ltd.（一家医疗激光和光技术公司）担任多种职位，包括业务发展总监、财务执行副总裁和财务总监。她持有Bar-Ilan University的工商管理硕士学位（金融方向），还从Haifa University。获得了经济与会计的学士学位。她还是一名注册会计师。
- Sharon Levita has served on our board of directors since September 2019. Ms. Levita also serves as business development and strategy leader at Medtronic. Prior to that, Ms. Levita has served as vice president operations and site leader of Mazor, as part of Medtronic, from December 2018 to January 2020 and as chief financial officer and vice president business operations of Mazor Robotics Ltd. from February 2008 to December 2018. Ms. Levita received her B.A in economics and accounting from the Haifa University, Israel and her M.A in business administration from the Bar-Ilan University, Israel. Ms. Levita is also a certificated public accountant in Israel.
高管简历
中英对照 | 中文 | 英文- Eyal Shamir
Eyal Shamir自2016年9月起担任我们的首席执行官，自2017年12月起担任董事会成员。Shamir先生拥有超过15年的医疗设备公司首席执行官的经验。他曾担任Erika Carmel Ltd.（2013年5月至2016年8月）、Tadbik Pack Ltd.（2011年1月至2012年12月）和Hanita Lens Ltd.（2006年至2010年）的首席执行官。Shamir先生在以色列希伯来大学获得经济学和商业管理学士学位，在以色列管理学院获得工商管理硕士学位。
Eyal Shamir has served as our Chief Executive Officer since September 2016 and on our board of directors since December 2017. Mr. Shamir has over 15 years of experience as chief executive officer of medical device companies. He has served as chief executive officer of Erika Carmel Ltd. from May 2013 to August 2016 Tadbik Pack Ltd. from January 2011 to December 2012 and Hanita Lenses Ltd. from 2006 to 2010. Mr. Shamir received his B.A. in economics and business management from the Hebrew University, Israel and his MBA from the College of Management Academic Studies, Israel.- Eyal Shamir自2016年9月起担任我们的首席执行官，自2017年12月起担任董事会成员。Shamir先生拥有超过15年的医疗设备公司首席执行官的经验。他曾担任Erika Carmel Ltd.（2013年5月至2016年8月）、Tadbik Pack Ltd.（2011年1月至2012年12月）和Hanita Lens Ltd.（2006年至2010年）的首席执行官。Shamir先生在以色列希伯来大学获得经济学和商业管理学士学位，在以色列管理学院获得工商管理硕士学位。
- Eyal Shamir has served as our Chief Executive Officer since September 2016 and on our board of directors since December 2017. Mr. Shamir has over 15 years of experience as chief executive officer of medical device companies. He has served as chief executive officer of Erika Carmel Ltd. from May 2013 to August 2016 Tadbik Pack Ltd. from January 2011 to December 2012 and Hanita Lenses Ltd. from 2006 to 2010. Mr. Shamir received his B.A. in economics and business management from the Hebrew University, Israel and his MBA from the College of Management Academic Studies, Israel.
- Ronen Tsimerman
Ronen Tsimerman自2017年5月起担任我们的首席财务官，自2018年5月起担任我们的首席运营官。Tsimerman先生拥有超过15年的担任上市和私人公司首席财务官的经验。他曾担任Insuline Medical Ltd.的首席财务官（从2015年6月到2017年5月）、MER-Group宽带部门TASE:CMER的首席财务官（从2005年到2013年）、MER-Group电信部门的财务副总裁（从2013年到2014年）。Tsimerman先生在以色列管理学院获得商业和工商管理硕士学位。
Ronen Tsimerman has served as our Chief Financial Officer since May 2017 and as our Chief Operation Officer since May 2018. Mr. Tsimerman has over 15 years of experience as chief financial officer of public and private companies. He has served as chief financial officer of Insuline Medical Ltd. from June 2015 to May 2017 as chief financial officer of Mer-Group Broadband division TASE: CMER from 2005 to 2013 and as vice president of finance of Mer-Group Telecom Division from 2013 to 2014. Mr. Tsimerman received his Bachelor in business and MBA from The College of Management, Israel.- Ronen Tsimerman自2017年5月起担任我们的首席财务官，自2018年5月起担任我们的首席运营官。Tsimerman先生拥有超过15年的担任上市和私人公司首席财务官的经验。他曾担任Insuline Medical Ltd.的首席财务官（从2015年6月到2017年5月）、MER-Group宽带部门TASE:CMER的首席财务官（从2005年到2013年）、MER-Group电信部门的财务副总裁（从2013年到2014年）。Tsimerman先生在以色列管理学院获得商业和工商管理硕士学位。
- Ronen Tsimerman has served as our Chief Financial Officer since May 2017 and as our Chief Operation Officer since May 2018. Mr. Tsimerman has over 15 years of experience as chief financial officer of public and private companies. He has served as chief financial officer of Insuline Medical Ltd. from June 2015 to May 2017 as chief financial officer of Mer-Group Broadband division TASE: CMER from 2005 to 2013 and as vice president of finance of Mer-Group Telecom Division from 2013 to 2014. Mr. Tsimerman received his Bachelor in business and MBA from The College of Management, Israel.
- Shay Levav
Shay Levav自2020年9月起担任我们的副总裁，负责监管和质量保证以及临床应用。在加入公司之前，Levav先生自2018年12月至2020年9月担任Applied Spectral Imaging的董事会成员，自2015年1月至2018年12月担任其质量和监管事务经理。他还从2012年到2015年担任Carestream Health Inc.的商业化业务经理，从2001年到2012年担任其运营质量经理，从2000年到2001年担任服务工程师。利瓦夫先生拥有以色列鲁宾学院中心的学士学位。
Shay Levav has served as our Vice President, Regulatory and Quality Assurance and Clinical Applications since September 2020. Before joining the Company, Mr. Levav has served as a member on the board of directors of Applied Spectral Imaging from December 2018 to September 2020 and as its quality and regulatory affairs manager since January 2015 to December 2018. He has also served as commercialization business manager of Carestream Health Inc. from 2012 to 2015 as its operations quality manager since 2001 to 2012 and service engineer since 2000 to 2001. Mr. Levav holds a B.A. from the Ruppin Academy Center, Israel.- Shay Levav自2020年9月起担任我们的副总裁，负责监管和质量保证以及临床应用。在加入公司之前，Levav先生自2018年12月至2020年9月担任Applied Spectral Imaging的董事会成员，自2015年1月至2018年12月担任其质量和监管事务经理。他还从2012年到2015年担任Carestream Health Inc.的商业化业务经理，从2001年到2012年担任其运营质量经理，从2000年到2001年担任服务工程师。利瓦夫先生拥有以色列鲁宾学院中心的学士学位。
- Shay Levav has served as our Vice President, Regulatory and Quality Assurance and Clinical Applications since September 2020. Before joining the Company, Mr. Levav has served as a member on the board of directors of Applied Spectral Imaging from December 2018 to September 2020 and as its quality and regulatory affairs manager since January 2015 to December 2018. He has also served as commercialization business manager of Carestream Health Inc. from 2012 to 2015 as its operations quality manager since 2001 to 2012 and service engineer since 2000 to 2001. Mr. Levav holds a B.A. from the Ruppin Academy Center, Israel.
- Tlalit Bussi Tel Tzure
Tlalit Bussi Tel Tzure自2018年12月起担任我们的副总裁，负责业务发展和全球营销。Bussi Tel-Tzure女士拥有超过20年的医疗器械公司的销售、业务开发和营销经验。她曾担任DIA Imaging Analysis Ltd.的营销副总裁（从2017年4月到2018年12月），以及Medical Compression System Ltd.的销售与市场营销的副总裁（从2012年9月到2017年8月）。Bussi Tel-Tzure女士在以色列希伯来大学获得理学学士学位，在英国赫里奥瓦特大学获得工商管理硕士学位。
Tlalit Bussi Tel Tzure has served as our Vice President, Business Development and Global Marketing, since December 2018. Ms. Bussi Tel-Tzure has more than 20 years of sales, business developments and marketing of medical device companies. She has served as vice president of marketing of DiA Imaging Analysis Ltd. form April 2017 to December 2018 and as vice president of sales and marketing of Medical Compression System Ltd. from September 2012 to August 2017. Ms. Bussi Tel-Tzure received her Bachelor of Science from the Hebrew University, Israel and her MBA from the Heriot-Watt University, United Kingdom.- Tlalit Bussi Tel Tzure自2018年12月起担任我们的副总裁，负责业务发展和全球营销。Bussi Tel-Tzure女士拥有超过20年的医疗器械公司的销售、业务开发和营销经验。她曾担任DIA Imaging Analysis Ltd.的营销副总裁（从2017年4月到2018年12月），以及Medical Compression System Ltd.的销售与市场营销的副总裁（从2012年9月到2017年8月）。Bussi Tel-Tzure女士在以色列希伯来大学获得理学学士学位，在英国赫里奥瓦特大学获得工商管理硕士学位。
- Tlalit Bussi Tel Tzure has served as our Vice President, Business Development and Global Marketing, since December 2018. Ms. Bussi Tel-Tzure has more than 20 years of sales, business developments and marketing of medical device companies. She has served as vice president of marketing of DiA Imaging Analysis Ltd. form April 2017 to December 2018 and as vice president of sales and marketing of Medical Compression System Ltd. from September 2012 to August 2017. Ms. Bussi Tel-Tzure received her Bachelor of Science from the Hebrew University, Israel and her MBA from the Heriot-Watt University, United Kingdom.
- Naum Muchnik
Naum Muchnik自2018年3月起担任我们的副总裁，负责研究、开发和工程。在此之前，Muchnik先生从2016年8月到2018年3月担任MedaSense Biometrics Ltd.的运营和服务经理，并担任GE医疗保健-超声波的研究与开发机械团队负责人和项目负责人。Muchnik先生获得了理学硕士学位。以色列Holon技术学院技术管理专业，以色列Ort Braude学院机械工程技术学士学位。
Naum Muchnik has served as our Vice President, Research, Development and Engineering since March 2018. Prior to that, Mr. Muchnik has served as operations and service manager of Medasense Biometrics Ltd. from August 2016 to March 2018 and as research and development mechanical team leader and project leader of GE Healthcare - Ultrasound. Mr. Muchnik received his M.Sc. in technology management from the Holon Technology Institute, Israel and Bachelor of Technology in mechanical engineering from the Ort Braude Academic College, Israel.- Naum Muchnik自2018年3月起担任我们的副总裁，负责研究、开发和工程。在此之前，Muchnik先生从2016年8月到2018年3月担任MedaSense Biometrics Ltd.的运营和服务经理，并担任GE医疗保健-超声波的研究与开发机械团队负责人和项目负责人。Muchnik先生获得了理学硕士学位。以色列Holon技术学院技术管理专业，以色列Ort Braude学院机械工程技术学士学位。
- Naum Muchnik has served as our Vice President, Research, Development and Engineering since March 2018. Prior to that, Mr. Muchnik has served as operations and service manager of Medasense Biometrics Ltd. from August 2016 to March 2018 and as research and development mechanical team leader and project leader of GE Healthcare - Ultrasound. Mr. Muchnik received his M.Sc. in technology management from the Holon Technology Institute, Israel and Bachelor of Technology in mechanical engineering from the Ort Braude Academic College, Israel.